EMD Serono, the US biopharma division of German pharma company Merck KGaA (MRK: DE), has appointed Scott Filosi as senior vice president of managed markets.
He will be responsible for developing and executing managed markets marketing, sales and contracting strategies to ensure market access.
Mr Filosi joins from UCB Pharma (Euronext: UCB) where he was head of US market access and pricing and head of established brands in the USA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze